| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.755 | 6.600 | 23.505 | 518.208 | 468.124 | 537.322 | 245.892 | 893.494 | 478.257 | 1.128.372 |
| Total Income - EUR | 9.760 | 6.600 | 23.517 | 543.588 | 453.799 | 551.320 | 247.578 | 923.459 | 538.330 | 1.208.727 |
| Total Expenses - EUR | 8.811 | 4.986 | 12.778 | 362.314 | 348.167 | 477.495 | 232.684 | 808.266 | 515.526 | 1.052.164 |
| Gross Profit/Loss - EUR | 948 | 1.615 | 10.738 | 181.275 | 105.632 | 73.825 | 14.894 | 115.193 | 22.804 | 156.563 |
| Net Profit/Loss - EUR | 656 | 1.417 | 10.033 | 176.093 | 100.962 | 68.948 | 12.835 | 113.731 | 17.910 | 117.877 |
| Employees | 0 | 0 | 0 | 1 | 3 | 7 | 4 | 0 | 10 | 0 |
Check the financial reports for the company - Izolatii Conducte S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 23.980 | 23.482 | 45.243 | 11.817 | 3.842 | 55.882 | 410.392 |
| Current Assets | 2.484 | 2.315 | 12.825 | 198.913 | 179.996 | 243.367 | 312.184 | 708.114 | 462.749 | 1.222.004 |
| Inventories | 379 | 257 | 4.546 | 98.244 | 117.076 | 196.401 | 231.095 | 151.499 | 199.377 | 278.714 |
| Receivables | 1.921 | 1.778 | 2.392 | 35.212 | 37.826 | 19.883 | 74.710 | 464.775 | 228.050 | 1.089.271 |
| Cash | 184 | 280 | 5.887 | 65.457 | 25.094 | 27.084 | 6.380 | 91.839 | 35.322 | -145.981 |
| Shareholders Funds | 836 | 2.244 | 12.240 | 176.222 | 101.787 | 99.857 | 56.225 | 170.232 | 48.894 | 146.395 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 0 | 101 | 101 | 101 |
| Debts | 1.648 | 70 | 585 | 47.379 | 103.105 | 193.841 | 267.776 | 541.724 | 469.737 | 1.486.001 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2059 - 2059" | |||||||||
| CAEN Financial Year |
2059
|
|||||||||
Comments - Izolatii Conducte S.r.l.